You are here

  • Home
  • Archive
  • Volume 84, Issue 11
  • ANTI GLUTAMIC ACID DECARBOXYLASE ANTIBODY MEDIATED ENCEPHALOPATHY WHILE ON ETANERCEPT IN A PATIENT WITH MULTIPLE AUTOIMMUNE DISEASES

Article info

Article menu
Download PDFPDF
Association of British Neurologists (ABN) joint meeting with the Royal College of Physicians (RCP), London, 23–24 October 2013
147
ANTI GLUTAMIC ACID DECARBOXYLASE ANTIBODY MEDIATED ENCEPHALOPATHY WHILE ON ETANERCEPT IN A PATIENT WITH MULTIPLE AUTOIMMUNE DISEASES

Authors

  • Niall MacDougall Institute of Neurological Sciences, Southern General, Glasgow; Department of Neurology, NHS Tayside, Ninewells Hospital and Medical School, Dundee PubMed articlesGoogle scholar articles
  • Briony Waddell Institute of Neurological Sciences, Southern General, Glasgow; Department of Neurology, NHS Tayside, Ninewells Hospital and Medical School, Dundee PubMed articlesGoogle scholar articles
  • Jonathan I O'Riordan Institute of Neurological Sciences, Southern General, Glasgow; Department of Neurology, NHS Tayside, Ninewells Hospital and Medical School, Dundee PubMed articlesGoogle scholar articles

    Citation

    MacDougall N, Waddell B, O'Riordan JI
    ANTI GLUTAMIC ACID DECARBOXYLASE ANTIBODY MEDIATED ENCEPHALOPATHY WHILE ON ETANERCEPT IN A PATIENT WITH MULTIPLE AUTOIMMUNE DISEASES
    Journal of Neurology, Neurosurgery & Psychiatry 2013;84:e2.

    Publication history

    • First published October 9, 2013.
    Online issue publication 
    February 19, 2018

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Copyright information

    Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions